AllQuantitative Report
Argus•April 07, 2021
Argus•April 07, 2021TRHC: Lowering target price to $34.00
Summary
Tabula Rasa HealthCare Inc is engaged in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcome
Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Actions
Download Full ReportRelated Reports
- APPF: Lowering target price to $236.00Apr 17, 2024 •
APPF
- SOLV: Lowering target price to $68.00Apr 17, 2024 •
SOLV
- GEV: Raising target price to $137.00Apr 17, 2024 •
GEV
- BL: Lowering target price to $63.00Apr 17, 2024 •
BL
- BGC: What does Argus have to say about BGC?Apr 17, 2024 •
BGC